Update on etiopathogenesis of systemic sclerosis (Q38183300)

30 August 2017

title

Update on etiopathogenesis of systemic sclerosis (English)

1 reference

30 August 2017

author name string

Adriana Fontes Zimmermann

series ordinal

1

1 reference

30 August 2017

Marcia Margaret Menezes Pizzichini

series ordinal

2

1 reference

30 August 2017

publication date

1 November 2013

1 reference

Revista Brasileira de reumatologia

30 August 2017

published in

1 reference

30 August 2017

volume

53

1 reference

30 August 2017

issue

6

1 reference

30 August 2017

page(s)

516-524

1 reference

Changes in causes of death in systemic sclerosis, 1972-2002

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Systemic sclerosis: the susceptible host (genetics and environment).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Silicone breast implants and connective tissue disease: no association

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Epidemiologic studies of environmental agents and systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

A polymorphism in the CTGF promoter region associated with systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Study of functional variants of theBANK1gene in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Mechanisms and consequences of fibrosis in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Raynaud phenomenon and the vascular disease in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Mechanisms of vascular damage in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

The pathogenesis of systemic sclerosis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Emerging targeted therapies in scleroderma lung and skin fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Fibrotic disease and the T(H)1/T(H)2 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Fibroproliferative Disorders and Their Mechanobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Tissue repair, contraction, and the myofibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Cellular and molecular mechanisms of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

STAT4is a genetic risk factor for systemic sclerosis having additive effects withIRF5on disease susceptibility and related pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

Association between theIRF5rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

BANK1is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects withIRF5andSTAT4

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.RBR.2013.01.001

10.1016/J.RBR.2013.01.001

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1033337554

0 references

1 reference